New MS treatment Ocrevus getting FDA approval
4:46
Fox NewsFox News
New MS treatment Ocrevus getting FDA approval
The U.S. Food and Drug Administration (FDA) on Tuesday approved Roche Holding AG's multiple sclerosis (MS) drug Ocrevus, putting the potential blockbuster drug back on track after a delay caused by regulators' concerns over manufacturing issues.
2017年7月24日
Ocrelizumab Side Effects
Ocrelizumab & the risk for infections
5:09
Ocrelizumab & the risk for infections
FacebookMSWorld
已浏览 13.6万 次2017年3月31日
Ozempic side effects could lead to hospitalization — and doctors warn that long-term impacts remain unknown
5:11
Ozempic side effects could lead to hospitalization — and doctors warn that long-term impacts remain unknown
wltx.com
2023年6月13日
The shocking Ozempic side effect that has medical professionals alarmed
The shocking Ozempic side effect that has medical professionals alarmed
7NEWSDigital Team
2023年7月27日
热门视频
Relapsing MS and Primary Progressive MS Treatment | OCREVUS® (ocrelizumab)
18:54
Relapsing MS and Primary Progressive MS Treatment | OCREVUS® (ocrelizumab)
ocrevus.com
2024年1月26日
OCREVUS® (ocrelizumab) | MS Treatment Experience
18:07
OCREVUS® (ocrelizumab) | MS Treatment Experience
ocrevus.com
2024年1月26日
Ocrevus (ocrelizumab)
Ocrevus (ocrelizumab)
mstrust.org.uk
2018年11月16日
Ocrelizumab Reviews
Ocrelizumab decision
2:26
Ocrelizumab decision
FacebookMultiple Sclerosis Trust
已浏览 6429 次2018年9月11日
OCREVUS® (ocrelizumab) on Instagram: "Pastell chooses OCREVUS for her MS treatment. And when she gets her infusion, this is what she takes. See Important Safety Information and Prescribing Information in our Highlights. OCREVUS is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, and primary progressive MS. It is not known if OCREVUS is safe
0:45
OCREVUS® (ocrelizumab) on Instagram: "Pastell chooses OCREVUS for her MS treatment. And when she gets her infusion, this is what she takes. See Important Safety Information and Prescribing Information in our Highlights. OCREVUS is a prescription medicine used to treat adults with relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, and primary progressive MS. It is not known if OCREVUS is safe
Instagramocrevus_ocrelizumab
已浏览 1378 次10 个月之前
Durvalumab FDA Approval for Bladder Cancer
Durvalumab FDA Approval for Bladder Cancer
onclive.com
2017年4月22日
反馈